NovoCure (NASDAQ:NVCR) Downgraded by StockNews.com to Sell
NovoCure (NASDAQ:NVCR – Get Free Report) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Monday. A number of other equities analysts have also weighed in on the company. HC Wainwright reissued a “buy” rating and issued a $38.00 target price on shares of NovoCure […]
NovoCure (NASDAQ:NVCR – Get Free Report) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Monday. A number of other equities analysts have also weighed in on the company. HC Wainwright reissued a “buy” rating and issued a $38.00 target price on shares of NovoCure […]
